DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

SRT-2104

Generic Name: SRT-2104

Drug Type: Small Molecule

Chemical Formula: C_₂₆H_₂₄N_₆O_₂S_₂

CAS Number: 1093403-33-8

Unique Ingredient Identifier: 4521NR0J09

Overview

SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular, and Diabetes Mellitus, Type 2.

Background

SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular, and Diabetes Mellitus, Type 2.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis

Phase 1

Completed

Posted: 2011/10/18

Sponsor:

Sirtris, a GSK Compa...

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Phase 2

Completed

Posted: 2010/06/30

Sponsor:

Sirtris, a GSK Compa...

A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers

Phase 1

Withdrawn

Posted: 2009/12/25

Sponsor:GlaxoSmithKline

A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus

Phase 1

Completed

Posted: 2009/12/14

Sponsor:

Sirtris, a GSK Compa...

A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus

Phase 2

Completed

Posted: 2009/11/23

Sponsor:GlaxoSmithKline

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy